27 September 2019,
10:30-12:00
Precision medicine’s mantra of participation and consumer driven health care constructs particular spaces for engagement and responsibilities around what it means to be a patient in the genomic era. Yet, participation and partnership enact processes of inclusion and exclusion in the crafting of a future when disease - in this case cancer - is expected to become more controlled through ‘the right treatment for the right patient at the right time’.
» Read more
